Patents Assigned to Sun Pharma Japan Limited
  • Cancer stem cell inhibitor
    Patent number: 11400076
    Abstract: The object of the present invention is to provide a novel pharmaceutical for suppressing cancer stem cells. In the present invention, a mitochondria inhibitor comprising a 2-nitroimidazole derivative is applied to the cancer stem cell as an active ingredient.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: August 2, 2022
    Assignees: KEIO UNIVERSITY, Sun Pharma Japan Limited
    Inventors: Hideyuki Saya, Oltea Sampetrean, Naoyoshi Koike, Nobuo Kubota